ArticleCureus2026
Eosinophilic Annular Erythema Associated With IgM Monoclonal Gammopathy of Undetermined Significance.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic annular erythema (EAE) is a rare inflammatory skin disease characterized by recurrent annular or figurate erythematous plaques and eosinophil-rich dermal infiltrates. Here, we present the case of a 73-year-old Japanese woman who had a 10-month history of pruritic annular and figurate plaques with central postinflammatory hyperpigmentation of the trunk and proximal extremities. Histopathological examination revealed dense perivascular and interstitial lymphocytic infiltrates with numerous eosinophils in the dermis, without vasculitis or flame figures, consistent with EAE. Laboratory evaluation revealed markedly elevated serum IgM, and immunofixation demonstrated an IgM-λ monoclonal protein with urinary λ-type Bence Jones protein. She was asymptomatic and had no evidence of end-organ damage, including hypercalcemia, renal insufficiency, anemia, or bone lesions. Additionally, the hematologic findings were consistent with a diagnosis of IgM monoclonal gammopathy of undetermined significance. The eruption regressed with high-potency topical corticosteroids, and the patient was managed with dermatological therapy and hematological surveillance. Reports of EAE associated with IgM monoclonal gammopathy are scarce. This case highlights that EAE may coexist with IgM monoclonal gammopathy and supports hematological evaluation and follow-up when IgM monoclonal proteins are detected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.